Sandoz targets barriers to biosimilar accessibility with latest initiative
The company hopes to work with stakeholders to improve access to biosimilars across the globe.
Agilent WP
US FDA approves Neobiosis’ IND for post-Covid syndrome therapy
China grants EUA to Covid-19 vaccine against XBB descendent lineages
EU agencies back Covid-19 vaccine update ahead of autumn campaign
Revised EU/Pfizer/BioNTech Covid-19 vaccine deal may lead to a Comirnaty monopoly
Novavax receives positive opinion from CHMP for full MA of Covid vaccine
ReNAgade Therapeutics enters RNA therapy arena with $300m
CureVac gets an early date in Covid-19 vaccine patent case with Pfizer/BioNTech
